What evidence‑based, step‑by‑step drug prescription algorithm for gestational diabetes mellitus (GDM) in an Indian hospital, suitable for a junior doctor, includes diagnostic thresholds, criteria for initiating pharmacotherapy, insulin initiation and dose titration, role and limitations of metformin and other oral agents, trimester‑specific considerations, contraindications, maternal‑fetal monitoring, hypoglycemia management, and intrapartum/postpartum medication adjustments according to ADA, ACOG and Indian guidelines?

Evidence-Based Drug Prescription Algorithm for Gestational Diabetes Mellitus (GDM) in Indian Hospital Setting

Insulin remains the first-line pharmacotherapy for GDM when lifestyle modification fails, but metformin is an acceptable alternative with specific caveats about increased preterm birth and small-for-gestational-age infants. 1

---

STEP 1: DIAGNOSIS

Diagnostic Thresholds (24-28 weeks gestation)

Use either One-Step OR Two-Step approach 2:

One-Step Strategy (IADPSG criteria):

• 75-g OGTT after 8-hour overnight fast
• GDM diagnosed if ANY ONE value meets/exceeds:
  • Fasting: ≥92 mg/dL (5.1 mmol/L)
  • 1-hour: ≥180 mg/dL (10.0 mmol/L)
  • 2-hour: ≥153 mg/dL (8.5 mmol/L)

Two-Step Strategy (Carpenter-Coustan):

• Step 1: 50-g non-fasting glucose load test
  • If ≥140 mg/dL at 1 hour → proceed to Step 2
  • (Use ≥130 or ≥135 mg/dL in high-risk populations)
• Step 2: 100-g OGTT (fasting)
  • GDM diagnosed if TWO OR MORE values meet/exceed:
    • Fasting: 95 mg/dL (5.3 mmol/L)
    • 1-hour: 180 mg/dL (10.0 mmol/L)
    • 2-hour: 155 mg/dL (8.6 mmol/L)
    • 3-hour: 140 mg/dL (7.8 mmol/L)

Indian Context Note: DIPSI (Diabetes in Pregnancy Study Group India) recommends a single 75-g glucose load (non-fasting) with 2-hour plasma glucose >140 mg/dL as diagnostic, which is simpler and endorsed by Ministry of Health India 3, 4. However, international guidelines (ADA, ACOG) use the criteria above.

---

STEP 2: INITIAL MANAGEMENT - LIFESTYLE MODIFICATION

All women with GDM start with Medical Nutrition Therapy (MNT) for 1-2 weeks 1:

Glycemic Targets During Lifestyle Phase:

• Fasting: <95 mg/dL (<5.3 mmol/L)
• 1-hour postprandial: <140 mg/dL (<7.8 mmol/L) OR
• 2-hour postprandial: <120 mg/dL (<6.7 mmol/L)

Monitoring Requirements:

• Self-monitoring blood glucose (SMBG): 4-7 times daily (fasting + postprandial)
• Document values for 1-2 weeks before escalating therapy

Proceed to pharmacotherapy if:

• ≥2 abnormal values in same time period over 1-2 weeks despite MNT
• Fasting glucose persistently ≥95 mg/dL
• Postprandial values persistently exceed targets
• Evidence of fetal macrosomia on ultrasound (abdominal circumference >75th percentile)

---

STEP 3: PHARMACOTHERAPY INITIATION

FIRST-LINE: INSULIN 5, 1

Insulin is preferred because:

• Does not cross placenta
• Most effective for all degrees of hyperglycemia
• Extensive safety data
• Can be titrated without upper dose limit

ALTERNATIVE: METFORMIN 1, 6

Metformin is acceptable when:

• Patient refuses insulin
• Cost/access barriers to insulin
• Patient preference after informed consent

Metformin Limitations & Warnings:

• Crosses placenta (70% of maternal levels in cord blood) 1
• Associated with increased preterm birth (RR varies by study)
• Associated with increased small-for-gestational-age (SGA) infants
• 30-50% of women require supplemental insulin for adequate control 1
• Contraindicated: Renal impairment (eGFR <45 mL/min), liver disease, heart failure, conditions predisposing to lactic acidosis 6

DO NOT USE GLYBURIDE: Meta-analyses show glyburide inferior to both insulin and metformin, with higher rates of neonatal hypoglycemia, macrosomia, and birth weight 1

---

STEP 4: INSULIN REGIMEN SELECTION & DOSING

Initial Insulin Calculation:

Total Daily Dose (TDD) = 0.7-1.0 units/kg current body weight 5

• Use lower end (0.7) in early pregnancy or lean women
• Use higher end (1.0) in third trimester or obese women

Regimen Selection Based on Glucose Pattern:

A. Fasting Hyperglycemia ONLY:

• NPH insulin or Insulin detemir at bedtime
• Start: 0.2 units/kg OR 10 units at bedtime
• Alternative: Insulin glargine 10 units at bedtime (off-label but acceptable) 5

B. Postprandial Hyperglycemia ONLY:

• Rapid-acting insulin analog before meals (lispro or aspart)
• Divide TDD: 50% breakfast, 25% lunch, 25% dinner
• Start: 2-4 units before largest meal, titrate based on postprandial values

C. Combined Fasting + Postprandial Hyperglycemia:

• Basal-bolus regimen:
  • 50% TDD as basal (NPH at bedtime or detemir/glargine)
  • 50% TDD divided as prandial (rapid-acting before meals)
  • Example: 70 kg woman → TDD 50 units → 25 units basal + 25 units prandial (10-8-7 distribution)

D. Severe/Uncontrolled Hyperglycemia:

• Consider twice-daily NPH (2/3 morning, 1/3 evening) + rapid-acting analogs before meals
• Requires specialist consultation

Insulin Types Approved in Pregnancy:

• Basal: NPH (preferred), detemir (Category B), glargine (acceptable, increasing evidence)
• Prandial: Lispro, aspart (Category B) 7, 5
• Avoid: Regular insulin as first-line (acceptable if analogs unavailable)

---

STEP 5: INSULIN TITRATION PROTOCOL

Titration Schedule:

Adjust every 3-7 days based on SMBG patterns:

Glucose Pattern	Adjustment
Fasting >95 mg/dL	Increase bedtime basal by 2-4 units (or 10-20%)
Pre-lunch high	Increase breakfast rapid-acting by 1-2 units
Pre-dinner high	Increase lunch rapid-acting by 1-2 units
Bedtime high	Increase dinner rapid-acting by 1-2 units
Postprandial >140 (1h) or >120 (2h)	Increase corresponding meal insulin by 1-2 units
Hypoglycemia (<70 mg/dL)	Decrease corresponding insulin by 2-4 units (or 10-20%)

Titration Principles:

• Adjust ONE insulin type at a time
• Wait 3 days to assess effect before next adjustment
• More aggressive titration acceptable if values markedly elevated (>180 mg/dL)
• Insulin requirements typically increase 50-100% from second to third trimester

---

STEP 6: METFORMIN DOSING (If Used)

Starting Dose:

• 500 mg once daily with dinner (reduce GI side effects)

Titration:

• Increase by 500 mg every 5-7 days as tolerated
• Target dose: 2000 mg/day (1000 mg twice daily with meals)
• Maximum dose: 2500 mg/day (850 mg three times daily)

Monitoring:

• Check fasting and postprandial glucose weekly
• If targets not met after 1-2 weeks at maximum dose → add insulin
• Approximately 30-50% will require supplemental insulin 1

Metformin + Insulin Combination:

• Continue metformin, add insulin as per Step 4
• May reduce total insulin requirements
• Monitor for hypoglycemia more closely

---

STEP 7: TRIMESTER-SPECIFIC CONSIDERATIONS

First Trimester (<14 weeks):

• Early screening indicated if: BMI >30, prior GDM, strong family history, PCOS, prior macrosomic infant
• Use standard non-pregnancy diabetes criteria (FPG ≥126 mg/dL = overt diabetes, not GDM) 2
• If diagnosed: Classify as pre-existing diabetes, not GDM
• Insulin preferred; metformin Category B but limited data

Second Trimester (14-28 weeks):

• Standard GDM screening at 24-28 weeks
• Insulin requirements begin increasing
• Initiate therapy promptly if lifestyle fails

Third Trimester (>28 weeks):

• Insulin requirements increase dramatically (insulin resistance peaks)
• Expect to increase doses by 50-100% from baseline
• Weekly dose adjustments often needed
• Fetal surveillance intensifies (NST, BPP starting 32-34 weeks if on medication)

---

STEP 8: MATERNAL-FETAL MONITORING

Maternal Monitoring:

Glycemic Monitoring:

• SMBG: 4-7 times daily (fasting + 1 or 2-hour postprandial after each meal)
• A1C every 4-6 weeks: Target <6% (<42 mmol/mol) if achievable without hypoglycemia; acceptable up to <7% (<53 mmol/mol) 5
• Note: A1C physiologically lower in pregnancy due to increased RBC turnover

Blood Pressure:

• Every visit (screen for preeclampsia)

Renal Function (if on metformin):

• Baseline creatinine/eGFR
• Repeat if clinical indication

Ketone Monitoring:

• Check urine ketones if fasting glucose >200 mg/dL or illness

Fetal Monitoring:

Ultrasound:

• Baseline anatomy scan at 18-20 weeks
• Growth scans every 3-4 weeks starting 28-32 weeks (assess for macrosomia, polyhydramnios)
• Abdominal circumference >75th percentile → consider intensifying therapy

Antenatal Testing:

• If diet-controlled GDM: Initiate at 40 weeks (or earlier if other indications)
• If medication-controlled GDM: Initiate at 32-34 weeks
• NST twice weekly OR BPP weekly

---

STEP 9: HYPOGLYCEMIA MANAGEMENT

Definition:

• Blood glucose <70 mg/dL (symptomatic or asymptomatic)
• Severe: <54 mg/dL or requiring assistance

Immediate Treatment (Rule of 15):

1. 15 grams fast-acting carbohydrate:
   • 3-4 glucose tablets OR
   • 120 mL fruit juice OR
   • 1 tablespoon honey/sugar
2. Recheck glucose in 15 minutes
3. Repeat if still <70 mg/dL
4. Once >70 mg/dL: Eat small snack with protein if next meal >1 hour away

Prevention:

• Reduce insulin dose by 10-20% after any hypoglycemic episode
• Review timing of insulin relative to meals
• Ensure adequate carbohydrate intake (minimum 175 g/day in pregnancy)
• Educate on early symptoms: shakiness, sweating, confusion, hunger

Severe Hypoglycemia:

• Glucagon 1 mg IM/SC (prescribe kit to all insulin-treated patients)
• Call emergency services
• Hospital admission for observation

---

STEP 10: INTRAPARTUM MANAGEMENT

Timing of Delivery:

Diet-controlled GDM:

• Expectant management until 40+6 weeks
• Induce if not spontaneous by 41 weeks

Medication-controlled GDM:

• Deliver by 39-40 weeks (individualize based on control, fetal size)
• Consider earlier if poor control or fetal concerns

Glucose Management During Labor:

Target: Maintain glucose 70-120 mg/dL during labor

Protocol:

1. Check glucose every 1-2 hours during active labor
2. Hold all subcutaneous insulin once active labor begins
3. If glucose >120 mg/dL:
   • Start IV regular insulin infusion: 0.5-1 unit/hour
   • Titrate to maintain 70-120 mg/dL
4. If glucose <70 mg/dL:
   • Give 5% or 10% dextrose IV
5. Avoid oral intake (NPO except ice chips)

Cesarean Section:

• Schedule as first case of morning if possible
• Hold morning insulin dose
• Check glucose pre-op and every 1-2 hours intra/post-op
• Use insulin infusion if needed

---

STEP 11: POSTPARTUM MEDICATION ADJUSTMENTS

Immediate Postpartum (0-24 hours):

DISCONTINUE ALL DIABETES MEDICATIONS immediately after delivery (insulin resistance resolves rapidly)

Glucose Monitoring:

• Check fasting glucose on postpartum day 1
• If <100 mg/dL → no further medication needed
• If ≥100 mg/dL → check again; consider endocrine consult if persistently elevated (suggests pre-existing diabetes)

Breastfeeding Considerations:

• Insulin: Safe during breastfeeding
• Metformin: Excreted in breast milk in small amounts; generally considered compatible but discuss risks/benefits

---

STEP 12: POSTPARTUM SCREENING & FOLLOW-UP

6-12 Weeks Postpartum:

Mandatory screening for persistent diabetes:

• 75-g OGTT (NOT A1C, due to recent pregnancy) 8, 9
• Use non-pregnancy diagnostic criteria:
  • Fasting ≥126 mg/dL = Diabetes
  • 2-hour ≥200 mg/dL = Diabetes
  • Fasting 100-125 mg/dL OR 2-hour 140-199 mg/dL = Prediabetes

If Prediabetes Diagnosed:

• Lifestyle intervention (weight loss, exercise)
• Metformin 850 mg twice daily (proven to reduce progression to diabetes) 8

If Normal:

• Rescreen every 1-3 years lifelong (50-70% lifetime risk of type 2 diabetes)

---

CONTRAINDICATIONS & SAFETY WARNINGS

Absolute Contraindications to Metformin:

• eGFR <45 mL/min/1.73m² (hold if <30)
• Acute/chronic metabolic acidosis
• Severe hepatic impairment
• Acute heart failure or unstable cardiovascular disease
• History of lactic acidosis
• Excessive alcohol intake
• Planned iodinated contrast procedure (hold 48 hours before/after)

Insulin Contraindications:

• Hypoglycemia (relative)
• No absolute contraindications

Red Flags Requiring Immediate Specialist Referral:

• Fasting glucose persistently >200 mg/dL despite maximum therapy
• Recurrent severe hypoglycemia
• Diabetic ketoacidosis (rare in GDM)
• Significant proteinuria or renal impairment
• Proliferative retinopathy
• Suspected type 1 diabetes (positive antibodies, ketosis)

---

COMMON PITFALLS TO AVOID

1. Delaying pharmacotherapy: Do not wait >2 weeks if lifestyle modification clearly failing
2. Undertitrating insulin: Pregnancy requires aggressive titration; doses often double by third trimester
3. Using glyburide: Inferior outcomes compared to insulin/metformin
4. Relying solely on A1C: Use SMBG as primary monitoring tool
5. Continuing diabetes medications postpartum: STOP immediately after delivery
6. Forgetting postpartum OGTT: 50% of women lost to follow-up; schedule before discharge
7. Using metformin without informed consent: Discuss increased preterm birth/SGA risk
8. Inadequate fetal surveillance: Medication-treated GDM requires NST starting 32-34 weeks

---

ALGORITHM SUMMARY FLOWCHART

GDM Diagnosis (24-28 weeks)
         ↓
Medical Nutrition Therapy (MNT) × 1-2 weeks
         ↓
Targets met? → YES → Continue MNT + monitoring
         ↓ NO
Pharmacotherapy needed
         ↓
    ┌────────┴────────┐
    ↓                 ↓
INSULIN            METFORMIN
(First-line)       (Alternative)
    ↓                 ↓
Calculate TDD      Start 500 mg daily
Select regimen     Titrate to 2000 mg
    ↓                 ↓
Titrate q3-7 days  Add insulin if inadequate
    ↓                 ↓
    └────────┬────────┘
         ↓
Maternal-Fetal Monitoring
(SMBG, A1C, ultrasound, NST)
         ↓
Intrapartum: Hold insulin, IV if needed
         ↓
Postpartum: STOP all medications
         ↓
6-12 weeks: 75-g OGTT screening
         ↓
Lifelong surveillance every 1-3 years

---

This algorithm synthesizes ADA 2, ACOG 1, AACE 7, and Indian guidelines 3, 4 with emphasis on practical implementation for junior doctors. All medication doses and monitoring parameters are evidence-based and suitable for real-world clinical practice in resource-variable settings.